Global leader debuts first wearable oscillometric wrist monitor, first Blood Pressure Monitor + EKG in the U.S. and new app that stores, tracks and shares more data
LAS VEGAS, NV, January 8, 2018 – In pursuit of its mission to eliminate heart attack and stroke, OMRON Healthcare, Inc. today unveiled breakthrough new innovations in personal heart health technology at the 2018 Consumer Electronics Show (CES). The global market leader in at-home blood pressure monitors debuted two devices that represent important category firsts: the OMRON HeartGuide™, the first wearable oscillometric wrist blood pressure monitor, and the OMRON Blood Pressure Monitor + EKG, the first single at-home device in the U.S. that measures blood pressure and EKG. OMRON also previewed its new OMRON Connect App which syncs with OMRON connected devices so consumers can store, track and share heart health
data with their doctors for better treatment and better outcomes.
“The innovation and firsts we are unveiling at CES show that we are focused on – and investing in – our mission of Going for Zero, the elimination of heart attack and stroke,” said OMRON Healthcare, Inc., President and CEO, Ranndy Kellogg. “According to the new scientific guidelines on blood pressure, 103 million Americans are now in the hypertensive range. With these new devices, OMRON Healthcare offers a range of blood pressure monitors to meet the needs and preferences of every one of them.”
OMRON HeartGuide
The OMRON HeartGuide, the first-ever wearable oscillometric wrist blood pressure monitor, comes in the form of a wristwatch with an inflatable cuff built into the watch band. The HeartGuide uses oscillometric measurement – the inflation of a cuff to measure systolic and diastolic pressure – which is still the only FDA-recognized standard for accurate, automated blood pressure measurement at home.
OMRON has made significant advancements in design and comfort over the wrist wearable prototype previewed last year. The market leader has filed over 50 new technology patents on the components developed for the HeartGuide, including miniaturization of blood pressure pumps, valves, and chips that has never been achieved previously. Some of the pumps and valves in the device are no larger than a grain of rice.
OMRON engineers used a flexible synthetic material five times stronger than steel to create the HeartGuide’s watch band. This rare material, which is used in the airbags of NASA’s Mars Lander, is strong yet flexible, allowing the band to inflate to take a reading while withstanding air pressure and maintaining its shape to ensure accurate measurement. The HeartGuide will mark the first time this material is used in a commercial health device.
“The wearable HeartGuide tracks sleep quality, and can be programmed to take a blood pressure reading while you sleep. Heart attack risk is higher in the last phase of sleep and in the morning. Checking blood pressure during sleep is an important option for hypertensive patients and an advancement in our pursuit of Going for Zero,” said Kellogg.
The OMRON HeartGuide will be submitted for FDA review later this year and will be clinically validated before it arrives for retail purchase.
OMRON Blood Pressure Monitor + EKG
The OMRON Blood Pressure Monitor + EKG is the first blood pressure monitor in the U.S. for use at home that can also simultaneously take an EKG (electrocardiogram) reading, addressing a previously unmet need. According to the CDC, six million Americans have atrial fibrillation (AFib) 1 . Their stroke risk is five times higher 2 . The OMRON Blood Pressure Monitor + EKG has the unprecedented ability to monitor two critical risk factors for stroke.
“Previously, heart arrhythmia and blood pressure could not be easily measured together, outside of a doctor’s office or hospital. The OMRON Blood Pressure Monitor + EKG allows people who have AFib, and are at a higher risk of stroke, to gain stronger insights into their condition and more control over the risks that come with it. Now, those with AFib can gain a more complete picture of their heart health from a single device. And they can do it anytime, at home,” said Kellogg.
OMRON developed this heart health technology with AliveCor, the market leader in FDA-cleared EKG technology. The OMRON Blood Pressure Monitor + EKG will be submitted to the FDA later this year and will be clinically validated before it is available for retail purchase.
New OMRON Connect App
Along with these innovative new devices, OMRON is previewing a new version of its smartphone app which syncs via Bluetooth ®3 with its connected heart health devices, including the HeartGuide, OMRON Blood Pressure Monitor + EKG and the EVOLV®. The OMRON Connect App allows users to store, track and share their heart health data with their doctors for deeper heart health insights which can lead to better treatment, and better outcomes.
The new OMRON Connect App can store a range of data collected by OMRON connected devices, including blood pressure, EKG and heart rate. The app’s easy-to- navigate, user-friendly interface features an intuitive dashboard that conveniently charts and graphs data – viewable by day, week, month or year – making it easy for users to keep close watch on their heart health trends.
“The OMRON Connect App encourages meaningful behavior change and more patient-doctor dialogue. With the app, users are encouraged to monitor their blood pressure regularly, to track their data over time and to share it with their doctors. More readings and more accurate data can be invaluable in making lifestyle and treatment changes and preventing cardiac events,” said Kellogg.
The new OMRON Connect App can be downloaded for free from the Apple iOS or Google Play stores in February 2018, in conjunction with Heart Health Month.
Going for Zero
OMRON Healthcare evolved its company mission to Going for Zero™, the elimination of heart attack and stroke in December 2016. In the last year, the company has pursued its bold mission by developing new heart health technologies, launching a national education campaign, and forming partnerships with like-minded companies like AliveCor, combining their collective strengths to achieve new category breakthroughs.
“Hypertension means increased risk for heart attack and stroke. Millions of people don’t know they have high blood pressure and are not aware of the risk they live with every day. The journey to better heart health begins with regular blood pressure monitoring,” said Kellogg.
For every visitor who checks into its Going for Zero booth at CES (#43722 in the Sands Expo at the Venetian), OMRON will donate a blood pressure monitor to the American Heart Association for their nationwide blood pressure management programs.
To learn more about the OMRON HeartGuide, the OMRON Blood Pressure Monitor + EKG, the OMRON Connect App and the company’s Going for Zero mission, visit OmronHealthcare.com and follow OMRON Healthcare, Inc. on Facebook, Twitter and LinkedIn.
###
About OMRON Healthcare, Inc.
OMRON Healthcare, Inc., is the world’s leading manufacturer and distributor of personal heart health and wellness products. OMRON’s market-leading products include home blood pressure monitors and electrotherapy devices. Since OMRON invented its first blood pressure monitors more than 40 years ago, the company has been passionate about empowering people to take charge of their health at home through precise technology. OMRON is the number one doctor and pharmacist recommended brand of blood pressure monitors for home use. The company’s mission is Going for Zero, the elimination of heart attacks and strokes. For more information, visit OmronHealthcare.com.
Media contact:
Rachel Winship
MWWPR for OMRON Healthcare
[email protected]
312.981.8544
1 https://www.cdc.gov/dhdsp/data_statistics/fact_sheets/fs_atrial_fibrillation.htm
2 https://www.heart.org/HEARTORG/Conditions/Arrhythmia/AboutArrhythmia/High-Blood- Pressure-AFib- and-Your-Risk-of-Stroke_UCM_443852_Article.jsp#
3 The Bluetooth word mark and logos are registered trademarks owned by the Bluetooth SIG, Inc. and any use of such marks by OMRON Healthcare, Inc. is under license. Other trademarks and trade names are those of their respective owners.